The compound you've described, 1-(3-methoxyphenyl)-3-(methyl-oxo-phenyl-$l^{6}$-sulfanylidene)thiourea, is not a well-established or widely studied chemical. There is no readily available information on its synthesis, properties, or potential applications in research.
It's possible that:
* **The structure is incomplete or inaccurate:** The formula you provided may contain errors or be missing crucial details.
* **The compound is novel:** It might be a newly synthesized compound not yet documented in scientific literature.
* **The nomenclature is non-standard:** The naming convention may not adhere to common chemical naming practices.
**Here's how to proceed:**
1. **Verify the chemical formula:** Double-check the structure and ensure all components are correctly represented.
2. **Consult chemical databases:** Search for the compound in databases like PubChem, ChemSpider, or Reaxys.
3. **Contact experts:** If you can't find information, consider reaching out to researchers specializing in organic chemistry or synthesis.
Without a clear and accurate structure, it's impossible to determine its importance for research. However, once the chemical identity is established, it's possible to explore its potential uses in:
* **Drug discovery:** Thiourea derivatives are known for their biological activity and are often investigated as potential pharmaceuticals.
* **Materials science:** Sulfur-containing compounds can have interesting properties for applications in materials development.
* **Organic chemistry:** The compound could be a novel reagent or intermediate in organic synthesis.
Remember that research is an ongoing process, and new compounds are constantly being discovered and studied. If this compound is indeed novel, its importance for research will depend on its unique properties and potential applications.
ID Source | ID |
---|---|
PubMed CID | 2820633 |
CHEBI ID | 93889 |
Synonym |
---|
MAYBRIDGE4_002325 |
SR-01000631659-1 |
NCGC00176677-01 |
HMS1527J15 |
BRD-A69336132-001-01-2 |
CCG-41595 |
CHEBI:93889 |
1-(3-methoxyphenyl)-3-(methyl-oxo-phenyl-lambda6-sulfanylidene)thiourea |
Q27165644 |
1-(3-methoxyphenyl)-3-(methyl-oxo-phenyl-$l^{6}-sulfanylidene)thiourea |
Class | Description |
---|---|
substituted aniline | |
methoxybenzenes | Any aromatic ether that consists of a benzene skeleton substituted with one or more methoxy groups. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | |||
AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6 | A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.13) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |